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EDITORIAL 
 
Tobacco Induced Diseases: 
A World-Wide Concern 
 
Prior to September 11, 2001, I along with many other 
Americans viewed the potential of terrorist attacks as 
something that occurred “over there” and “not here.” 
On that day, we began to understand that we are all part 
of a global community where events in one part of the 
world impact so many others. And, that we – all citi-
zens of the world – share problems and plagues, as well 
as the potential for solutions and health. Our differences 
are, perhaps, outweighed by our similarities. Clearly, 
the impact of tobacco induced disease has been an 
equal opportunity visitor to all countries of the globe. 
The current issue of this journal reflects that global 
concern. 
In this issue of the journal there are seven excel-
lent contributions to the global task of addressing the 
problem of tobacco addiction and its health conse-
quences. They are from all corners of the world – Can-
ada (two contributions), Sweden, the United Kingdom, 
Germany, the United States and Japan – and are repre-
sentative of the Society for the Prevention of Tobacco 
Induced Diseases (PTID) membership. They also illus-
trate the broad range of interest, topics, and research 
methods needed to examine the issue of tobacco addic-
tion, with studies ranging from behavioral interventions 
to basic science examinations. 
Drs. Chan and Koren from Canada address the 
many concerns associated with smoking during preg-
nancy, including miscarriage, preterm delivery and 
stillbirth. In this extensive review of published studies – 
122 are reviewed – the results reveal greater nicotine 
metabolism in pregnant individuals who continue to 
smoke during pregnancy. The studies support current 
guidelines from several health organizations, which 
uniformly recommend that Nicotine Replacement Ther-
apy should be considered if non-pharmacological thera-
pies have been unsuccessful. The authors conclude with 
a call for further studies on the safety and effectiveness 
of Nicotine Replacement Therapy and bupropion use 
during pregnancy. However, they stress that given the 
current research and guidelines, pharmacological cessa-
tion aids should be considered if non-pharmacological 
therapies have not been effective. 
Drs. Johansson, Halling, and the LinQuest Study 
Group from Sweden point out that smoking prevalence 
and smoking behaviours have changed in society, and 
an increased awareness of the importance of protecting 
children from environmental tobacco smoke (ETS) is 
reported. Their study aims to determine if smoking 
prevalence and smoking behaviours were influenced by 
parenthood, and if differences in health-related quality 
of life differed between smoking and non-smoking par-
ents. The researchers find that parenthood did not seem 
to be associated with lower smoking prevalence. Logis-
tic regression models showed that smoking prevalence 
was significantly associated with education, gender and 
mental health. Smoking behaviour, as well as attitudes 
toward passive smoking, seemed to be influenced by 
parenthood. Johansson and colleagues conclude that 
smoking behaviour, but not smoking prevalence, seems 
to be influenced by parenthood, and they stress the 
importance of commonly-used precautions when chil-
dren’s risk for ETS exposure is estimated. 
Drs. Unal, Critchley, and Capewell from the 
United Kingdom explore how much of the coronary 
heart disease (CHD) mortality fall in England and 
Wales can be attributed to changes in smoking preva-
lence. Their study uses a previously validated cell-
based IMPACT CHD mortality model to estimate the 
deaths prevented or postponed by changes in population 
smoking prevalence in England and Wales between 
1981 and 2000. They report that large declines in smok-
ing prevalence accounted for 29,460 fewer CHD deaths 
in England and Wales in 2000 compared with 1981. 
This emphasizes the importance of employing a na-
tional strategy with comprehensive tobacco control 
programs to further reduce smoking. It would be pru-
dent for those in other countries to consider these rec-
ommendations as well.  
There are four basic science contributions in this 
issue. Dr. Meisel and colleagues from Germany address 
the significant dose-effect relationship between the ex-
posure to tobacco smoke and the extent of periodontal 
disease, assessed as attachment loss and tooth loss. 
They provide support for the hypothesis that subjects 
who smoke and who bear genetic variants of polymor-
phically expressed phenotypes are at an increased risk 
of periodontitis. This may occur through the influence 
of smoking-related impairment on defense mechanisms, 
rather than on the pathogenic pathways. 
Drs. Lam and colleagues from Canada demonstrate 
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the direct in vitro release of the free radical nitric oxide 
(
•NO) from extracts and components of smokeless to-
bacco, in phosphate buffered saline and human saliva 
using electron spin resonance and chemiluminescence 
detection. Their findings suggest that tobacco xenobiot-
ics represent as yet unrecognized sources of 
•NO in the 
body.  
Dr. Chowdhury from the United States addresses 
the critical issue of cigarette smoking as a known major 
risk factor for pancreatic cancer and pancreatitis. He 
systematically studied the pathogenesis of pancreatitis 
and pancreatic cancer using a rodent model. His results 
suggest that alterations in metabolic, hormonal and 
pathologic parameters following nicotine treatment 
appear consistent with diagnostic criteria of human 
pancreatitis. Thus, it is likely that rats could be consid-
ered as a potential animal model to study the patho-
genesis of pancreatitis. 
Finally Drs. Aoshiba and Nagai from Japan re-
view and discuss oxidative stress, cell death, and other 
damage to alveolar epithelial cells as induced by ciga-
rette smoke. 
These excellent articles provide the reader with 
an opportunity to explore issues that arise during the 
global task of improving the world health. We welcome 
letters to the editor regarding these contributions as yet 
another method to further our knowledge of these im-
portant lines of inquiry. 
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Editor 
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